These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20230546)

  • 41. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?
    Pickard AS; Wang Z; Walton SM; Lee TA
    Health Qual Life Outcomes; 2005 Mar; 3():11. PubMed ID: 15748287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.
    Nerich V; Saing S; Gamper EM; Holzner B; Pivot X; Viney R; Kemmler G
    Breast Cancer Res Treat; 2017 Aug; 164(3):527-536. PubMed ID: 28497177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.
    Ahmad H; Taylor BV; van der Mei I; Colman S; O'Leary BA; Breslin M; Palmer AJ
    Mult Scler; 2017 Jul; 23(8):1157-1166. PubMed ID: 27698247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimating health state utility values for joint health conditions: a conceptual review and critique of the current evidence.
    Ara R; Wailoo AJ
    Med Decis Making; 2013 Feb; 33(2):139-53. PubMed ID: 22927696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimating Health State Utility Values for Comorbidities.
    Ara R; Brazier J
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):89-94. PubMed ID: 29052158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimating health state utility values from discrete choice experiments--a QALY space model approach.
    Gu Y; Norman R; Viney R
    Health Econ; 2014 Sep; 23(9):1098-114. PubMed ID: 24943827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression.
    Wang Y; Gavan SP; Steinke D; Cheung KL; Chen LC
    Health Qual Life Outcomes; 2022 Dec; 20(1):169. PubMed ID: 36564800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systematic review of health state utility values for acute myeloid leukemia.
    Forsythe A; Brandt PS; Dolph M; Patel S; Rabe APJ; Tremblay G
    Clinicoecon Outcomes Res; 2018; 10():83-92. PubMed ID: 29416365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health State Utility Values in Schizophrenia: A Systematic Review and Meta-Analysis.
    Aceituno D; Pennington M; Iruretagoyena B; Prina AM; McCrone P
    Value Health; 2020 Sep; 23(9):1256-1267. PubMed ID: 32940244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparing Increments in Utility of Health: An Individual-based Approach.
    Taylor M; Chilton S; Ronaldson S; Metcalf H; Nielsen JS
    Value Health; 2017 Feb; 20(2):224-229. PubMed ID: 28237199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Limitations of the methods used for calculating quality-adjusted life-year values.
    Duru G; Auray JP; Béresniak A; Lamure M; Paine A; Nicoloyannis N
    Pharmacoeconomics; 2002; 20(7):463-73. PubMed ID: 12093302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power Prior.
    Hatswell AJ
    Value Health; 2023 Sep; 26(9):1389-1397. PubMed ID: 37187235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nothing About Us Without Us? A Comparison of Adolescent and Adult Health-State Values for the Child Health Utility-9D Using Profile Case Best-Worst Scaling.
    Ratcliffe J; Huynh E; Stevens K; Brazier J; Sawyer M; Flynn T
    Health Econ; 2016 Apr; 25(4):486-96. PubMed ID: 25689621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic review of health state utility values for economic evaluation of colorectal cancer.
    Jeong K; Cairns J
    Health Econ Rev; 2016 Dec; 6(1):36. PubMed ID: 27541298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies.
    Ara R; Brazier J; Young T
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):67-75. PubMed ID: 29052159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?
    Peasgood T; Brazier J
    Pharmacoeconomics; 2015 Nov; 33(11):1101-5. PubMed ID: 26133293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland.
    Petrou S; Kupek E
    Med Decis Making; 2009; 29(3):291-303. PubMed ID: 19264726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Health state values from multiattribute utility instruments need correction.
    Nord E
    Ann Med; 2001 Jul; 33(5):371-4. PubMed ID: 11491196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Setting Dead at Zero: Applying Scale Properties to the QALY Model.
    Roudijk B; Donders ART; Stalmeier PFM
    Med Decis Making; 2018 Aug; 38(6):627-634. PubMed ID: 29629848
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.